Due to restrictions following results are derived from synthetic data to demonstrate capability of Computational Healthcare. Please do no derive any inferences from results below.

Rehospitalizations

Numerator 230

Discharged

Denominator 860

Rehospitalization Rate

230 / 860 = 26.7 %

Index = Discharged + Died + Transferred

930 (100%) = 860 (92.5%) + 0 (0.0%) + 0 (0.0%)

Aggregation Policy
Minimum count20
Multiple10
Min hospitals2
Min subset200

Rehospitalization during 50 days since discharge:

Mean ΔT: 27.46 days FQ: 9 days Median: 21 days TQ: 41 days

Rehospitalization during 50 weeks since discharge:

Mean ΔT: 3.48 weeks FQ: 1 weeks Median: 3 weeks TQ: 5 weeks
Sex Distribution
Sex Initial Sub Discharged
Male 56.52 % 56.52 % 44.19 %
Female 39.13 % 39.13 % 53.49 %
Race Distribution
Race Initial Sub Discharged
White 13.04 % 13.04 % 13.95 %
Black 13.04 % 13.04 % 15.12 %
Hispanic 13.04 % 13.04 % 12.79 %
Asian or Pacific Islander 8.7 % 13.04 % 11.63 %
Native American 13.04 % 13.04 % 15.12 %
Other 13.04 % 13.04 % 13.95 %
Race missing, unknown 13.04 % 8.7 % 13.95 %
Payer Distribution
Payer Initial Sub Discharged
Medicare 13.04 % 13.04 % 15.12 %
Medicaid 13.04 % 13.04 % 12.79 %
Private insurance 8.7 % 8.7 % 13.95 %
Self-pay 13.04 % 13.04 % 13.95 %
Other payer 8.7 % 17.39 % 13.95 %
Unknown payer 13.04 % 8.7 % 11.63 %
No charge 13.04 % 13.04 % 15.12 %
Source Distribution
Source Initial Sub Discharged
Another health facility including LTC 17.39 % 13.04 % 18.6 %
Emergency department 17.39 % 17.39 % 18.6 %
Unknown 13.04 % 17.39 % 13.95 %
Court/Law enforcement 17.39 % 8.7 % 16.28 %
Routine, birth, etc 13.04 % 17.39 % 15.12 %
Another hospital 13.04 % 17.39 % 13.95 %
Disposition Distribution
Disposition Initial Sub Discharged
Home Health Care 26.09 % 17.39 % 18.6 %
Died in hospital 0.0 % 13.04 % 0.0 %
Transfer other SNF, ICF, etc. 17.39 % 17.39 % 18.6 %
Routine 52.17 % 39.13 % 60.47 %
Length of Stay Distribution
Discharged
Initial
Subsequent
Visits Mean LOS First quartile Median Third quartile
Discharged 8.43 days 2 days 5 days 11 days
Initial 10.12 days 4 days 7 days 13 days
Sub 7.57 days 3 days 5 days 8 days
Age Distribution
Discharged
Initial
Subsequent
Visits Mean Age First quartile Median Third quartile
Discharged 65.56 year 55 year 67 year 77 year
Initial 68.05 year 59 year 70 year 78 year
Sub 68.2 year 59 year 69 year 80 year
Procedure Distribution
Procedure Code Description Initial Sub Discharged
P3326 Closed [percutaneous] [needle] biopsy of lung 0.0 % 0.0 % 2.33 %
P3324 Closed [endoscopic] biopsy of bronchus 0.0 % 0.0 % 2.33 %
P3893 Venous catheterization, not elsewhere classified 8.7 % 8.7 % 5.81 %
P3491 Thoracentesis 0.0 % 0.0 % 2.33 %
P9229 Other radiotherapeutic procedure 100.0 % 17.39 % 100.0 %
P9925 Injection or infusion of cancer chemotherapeutic substance 21.74 % 8.7 % 12.79 %
P9904 Transfusion of packed cells 17.39 % 21.74 % 12.79 %
DRG Distribution
DRG Code Description Initial Sub Discharged
DG409 DRG V24 : RADIOTHERAPY 0.0 % 0.0 % 5.81 %
DG301 DRG V24 : ENDOCRINE DISORDERS W/O CC 0.0 % 0.0 % 16.28 %
DG300 DRG V24 : ENDOCRINE DISORDERS W CC 0.0 % 0.0 % 4.65 %
DG10 DRG V24 : NERVOUS SYSTEM NEOPLASMS W CC 8.7 % 0.0 % 9.3 %
DG239 DRG V24 : PATHOLOGICAL FRACTURES & MUSCULOSKELETAL & CONN TISS MALIGNANCY 8.7 % 0.0 % 9.3 %
DG410 DRG V24 : CHEMOTHERAPY W/O ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS 0.0 % 0.0 % 2.33 %
DG82 DRG V24 : RESPIRATORY NEOPLASMS 8.7 % 8.7 % 6.98 %
DG403 DRG V24 : LYMPHOMA & NON-ACUTE LEUKEMIA W CC 0.0 % 0.0 % 2.33 %
Diagnosis Distribution
Diagnosis Code Description Initial Primary Sub Primary Discharged Primary Initial All Sub All Discharged All
D311 Depressive disorder, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D193 Malignant neoplasm of thyroid gland 0.0% 0.0% 20.93% 0.0% 0.0% 23.26%
D3383 Neoplasm related pain (acute) (chronic) 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D56400 Constipation, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D2761 Hyposmolality and/or hyponatremia 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D1970 Secondary malignant neoplasm of lung 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D496 Chronic airway obstruction, not elsewhere classified 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
DV103 Personal history of malignant neoplasm of breast 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D1977 Malignant neoplasm of liver, secondary 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
DV580 Encounter for radiotherapy 0.0% 0.0% 5.81% 0.0% 0.0% 5.81%
D19889 Secondary malignant neoplasm of other specified sites 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D53081 Esophageal reflux 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D1629 Malignant neoplasm of bronchus and lung, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D73300 Osteoporosis, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D25000 Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D28522 Anemia in neoplastic disease 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D2724 Other and unspecified hyperlipidemia 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
DV5811 Encounter for antineoplastic chemotherapy 0.0% 0.0% 2.33% 0.0% 0.0% 3.49%
D2859 Anemia, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 5.81%
D4019 Unspecified essential hypertension 0.0% 0.0% 0.0% 13.04% 13.04% 18.6%
D30000 Anxiety state, unspecified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D2768 Hypopotassemia 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D1960 Secondary and unspecified malignant neoplasm of lymph nodes of head, face, and neck 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D2720 Pure hypercholesterolemia 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D3051 Tobacco use disorder 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D2449 Unspecified acquired hypothyroidism 0.0% 0.0% 0.0% 0.0% 0.0% 3.49%
D27651 Dehydration 0.0% 0.0% 0.0% 0.0% 0.0% 4.65%
D78701 Nausea with vomiting 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
DV1582 Personal history of tobacco use 0.0% 0.0% 0.0% 8.7% 8.7% 8.14%
D5990 Urinary tract infection, site not specified 0.0% 0.0% 0.0% 0.0% 0.0% 2.33%
D1985 Secondary malignant neoplasm of bone and bone marrow 13.04% 0.0% 9.3% 17.39% 13.04% 12.79%
D1983 Secondary malignant neoplasm of brain and spinal cord 8.7% 0.0% 9.3% 8.7% 8.7% 8.14%
External Causes Distribution
External Cause Code Description Initial Sub Discharged
EE9331 Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use 8.7 % 0.0 % 6.98 %
EE8490 Accident in home 0.0 % 8.7 % 4.65 %
EE8497 Accidents occurring in residential institution 13.04 % 8.7 % 10.47 %
EE9320 Adrenal cortical steroids causing adverse effects in therapeutic use 0.0 % 0.0 % 3.49 %